Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
!!Link opens in a new tab
!!Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Anti-sense approach to anticholinesterase therapeutics
H. Soreq
, S. Seidman
Alexander Silberman Institute of Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-sense approach to anticholinesterase therapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Cholinesterase Inhibitor
100%
Acetylcholinesterase
100%
Diseases
60%
Acetylcholine
20%
Cholinergic Receptor Stimulating Agent
20%
Molecular Target
20%
Hydrolase
20%
Myasthenia gravis
20%
Antisense Oligonucleotide
20%
Messenger RNA
20%
Etiology
20%
Neuroscience
Acetylcholinesterase Inhibitor
100%
Acetylcholinesterase
100%
Gene Expression
20%
Cholinergic
20%
Antisense Oligonucleotide
20%
Acetylcholine
20%
Myasthenia gravis
20%
Hydrolase
20%
Messenger RNA
20%
Protein Tertiary Structure
20%
Keyphrases
Alzhiemer's Disease
33%